Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Evaluation
 

Gastrointestinal Perforation Associated with Bevacizumab Therapy
Processing...

MyLikes

MyPaths

Info
Algorithm Information

Gastrointestinal Perforation Associated with Bevacizumab Therapy

MyLikes

MyPaths
Purpose:
To evaluate a patient being treated with bevacizumab for signs of gastrointestinal (GI) tract perforation.
Specialty
  • Hematology Oncology
    Gastroenterology
Objective
  • Adverse effects
ICD-10
  • T45.1
References
Interpretation and Description
Share this Algorithm
MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Gastrointestinal Perforation Associated with Bevacizumab Therapy
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.